Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.

Summary

This exploratory study will be conducted open label in a single investigational clinical unit. Altogether 52 patients with benign prostate hyperplasia (BPH) will be randomly assigned to receive 4 different treatments with degarelix.

Timeline

Start

2007-10

Primary completion

2009-03

Completion

2009-05

Drugs

Indications